Globally, the health community is moving to a point where there could be zero new HIV infections or deaths. But it has been a long road.

The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa.
Epa/Maurizio Gambarini
December 21, 2015